484 related articles for article (PubMed ID: 31145370)
21. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism.
Magill SB; Raff H; Shaker JL; Brickner RC; Knechtges TE; Kehoe ME; Findling JW
J Clin Endocrinol Metab; 2001 Mar; 86(3):1066-71. PubMed ID: 11238487
[TBL] [Abstract][Full Text] [Related]
22. Effect of Eplerenone on the Glomerular Filtration Rate (GFR) in Primary Aldosteronism: Sequential Changes in the GFR During Preoperative Eplerenone Treatment to Subsequent Adrenalectomy.
Nakano Y; Yoshimoto T; Fukuda T; Murakami M; Bouchi R; Minami I; Hashimoto K; Fujii Y; Kihara K; Ogawa Y
Intern Med; 2018 Sep; 57(17):2459-2466. PubMed ID: 29709927
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis and management of primary aldosteronism.
Vilela LAP; Almeida MQ
Arch Endocrinol Metab; 2017; 61(3):305-312. PubMed ID: 28699986
[TBL] [Abstract][Full Text] [Related]
24. Quality of Life in Primary Aldosteronism: A Comparative Effectiveness Study of Adrenalectomy and Medical Treatment.
Velema M; Dekkers T; Hermus A; Timmers H; Lenders J; Groenewoud H; Schultze Kool L; Langenhuijsen J; Prejbisz A; van der Wilt GJ; Deinum J;
J Clin Endocrinol Metab; 2018 Jan; 103(1):16-24. PubMed ID: 29099925
[TBL] [Abstract][Full Text] [Related]
25. Association Between Acute Fall in Estimated Glomerular Filtration Rate After Treatment for Primary Aldosteronism and Long-Term Decline in Renal Function.
Kobayashi H; Abe M; Nakamura Y; Takahashi K; Fujita M; Takeda Y; Yoneda T; Kurihara I; Itoh H; Tsuiki M; Wada N; Ichijo T; Katabami T; Ogawa Y; Kawashima J; Yoshimoto T; Sone M; Inagaki N; Watanabe M; Kamemura K; Matsuda Y; Izawa S; Tanabe M; Tanabe A; Suzuki T; Naruse M;
Hypertension; 2019 Sep; 74(3):630-638. PubMed ID: 31327258
[TBL] [Abstract][Full Text] [Related]
26. Adrenal Vein Sampling Lateralization Despite Mineralocorticoid Receptor Antagonists Exposure in Primary Aldosteronism.
Nanba AT; Wannachalee T; Shields JJ; Byrd JB; Rainey WE; Auchus RJ; Turcu AF
J Clin Endocrinol Metab; 2019 Feb; 104(2):487-492. PubMed ID: 30239792
[TBL] [Abstract][Full Text] [Related]
27. Immunohistopathology and Steroid Profiles Associated With Biochemical Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism.
Meyer LS; Wang X; Sušnik E; Burrello J; Burrello A; Castellano I; Eisenhofer G; Fallo F; Kline GA; Knösel T; Kocjan T; Lenders JWM; Mulatero P; Naruse M; Nishikawa T; Peitzsch M; Rump LC; Beuschlein F; Hahner S; Gomez-Sanchez CE; Reincke M; Williams TA
Hypertension; 2018 Sep; 72(3):650-657. PubMed ID: 30012870
[TBL] [Abstract][Full Text] [Related]
28. Association of Adrenal Venous Sampling With Outcomes in Primary Aldosteronism for Unilateral Adenomas.
Thiesmeyer JW; Ullmann TM; Stamatiou AT; Limberg J; Stefanova D; Beninato T; Finnerty BM; Vignaud T; Leclerc J; Fahey TJ; Brunaud L; Mirallie E; Zarnegar R
JAMA Surg; 2021 Feb; 156(2):165-171. PubMed ID: 33146695
[TBL] [Abstract][Full Text] [Related]
29. Does contralateral suppression at adrenal venous sampling predict outcome following unilateral adrenalectomy for primary aldosteronism? A retrospective study.
Wolley MJ; Gordon RD; Ahmed AH; Stowasser M
J Clin Endocrinol Metab; 2015 Apr; 100(4):1477-84. PubMed ID: 25636049
[TBL] [Abstract][Full Text] [Related]
30. Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy.
Yoneda T; Demura M; Takata H; Kometani M; Karashima S; Yamagishi M; Takeda Y
J Clin Endocrinol Metab; 2012 Apr; 97(4):1109-13. PubMed ID: 22337911
[TBL] [Abstract][Full Text] [Related]
31. Worsening of lipid metabolism after successful treatment of primary aldosteronism.
Adolf C; Asbach E; Dietz AS; Lang K; Hahner S; Quinkler M; Rump LC; Bidlingmaier M; Treitl M; Ladurner R; Beuschlein F; Reincke M
Endocrine; 2016 Oct; 54(1):198-205. PubMed ID: 27179655
[TBL] [Abstract][Full Text] [Related]
32. Eplerenone improves carotid intima-media thickness (IMT) in patients with primary aldosteronism.
Matsuda Y; Kawate H; Matsuzaki C; Sakamoto R; Shibue K; Ohnaka K; Anzai K; Nomura M; Takayanagi R
Endocr J; 2016; 63(3):249-55. PubMed ID: 26727302
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic outcome of primary aldosteronism: adrenalectomy versus enucleation of aldosterone-producing adenoma.
Nakada T; Kubota Y; Sasagawa I; Yagisawa T; Watanabe M; Ishigooka M
J Urol; 1995 Jun; 153(6):1775-80. PubMed ID: 7752314
[TBL] [Abstract][Full Text] [Related]
34. Accuracy of adrenal imaging and adrenal venous sampling in predicting surgical cure of primary aldosteronism.
Lim V; Guo Q; Grant CS; Thompson GB; Richards ML; Farley DR; Young WF
J Clin Endocrinol Metab; 2014 Aug; 99(8):2712-9. PubMed ID: 24796926
[TBL] [Abstract][Full Text] [Related]
35. Time-Dependent Risk of Atrial Fibrillation in Patients With Primary Aldosteronism After Medical or Surgical Treatment Initiation.
Kim KJ; Hong N; Yu MH; Lee H; Lee S; Lim JS; Rhee Y
Hypertension; 2021 Jun; 77(6):1964-1973. PubMed ID: 33866798
[TBL] [Abstract][Full Text] [Related]
36. Prediction of successful outcome in patients with primary aldosteronism.
Moo TA; Zarnegar R; Duh QY
Curr Treat Options Oncol; 2007 Aug; 8(4):314-21. PubMed ID: 18058076
[TBL] [Abstract][Full Text] [Related]
37. Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling.
Omura M; Sasano H; Fujiwara T; Yamaguchi K; Nishikawa T
Metabolism; 2002 Mar; 51(3):350-5. PubMed ID: 11887172
[TBL] [Abstract][Full Text] [Related]
38. Reversal of arterial stiffness in medically and surgically treated unilateral primary aldosteronism.
Chen ZW; Liao CW; Pan CT; Tsai CH; Chang YY; Chang CC; Lee BC; Chiu YW; Huang WC; Lai TS; Lu CC; Chueh JS; Wu VC; Hung CS; Lin YH;
J Hypertens; 2024 Mar; 42(3):538-545. PubMed ID: 38088428
[TBL] [Abstract][Full Text] [Related]
39. Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial.
Dekkers T; Prejbisz A; Kool LJS; Groenewoud HJMM; Velema M; Spiering W; Kołodziejczyk-Kruk S; Arntz M; Kądziela J; Langenhuijsen JF; Kerstens MN; van den Meiracker AH; van den Born BJ; Sweep FCGJ; Hermus ARMM; Januszewicz A; Ligthart-Naber AF; Makai P; van der Wilt GJ; Lenders JWM; Deinum J;
Lancet Diabetes Endocrinol; 2016 Sep; 4(9):739-746. PubMed ID: 27325147
[TBL] [Abstract][Full Text] [Related]
40. Long-term effects of primary aldosteronism treatment on patients with primary aldosteronism and chronic kidney disease.
Nakano Y; Murakami M; Hara K; Fukuda T; Horino M; Takeuchi A; Niitsu Y; Shiba K; Tsujimoto K; Komiya C; Yokoyama M; Ikeda K; Yoshimoto T; Fujii Y; Yamada T
Clin Endocrinol (Oxf); 2023 Mar; 98(3):323-331. PubMed ID: 36367014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
